Regulatory News
Wednesday, November 9, 2016
BRIEF-Adaptimmune announces removal of partial clinical hold in MRCLS
* Adaptimmune announces removal of partial clinical hold in
myxoid/round cell liposarcoma (MRCLS)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment